Drug intelligence / Profile preview

Cold Phrenic Granules

Development stage: Preclinical
Administration: Oral

Overview

Cold Phrenic Granules is a Traditional Chinese Medicine (TCM) formula presented in a granule dosage form. It is primarily used for clearing heat, detoxifying, purging fire, and promoting bowel movement. The formula is indicated for conditions characterized by accumulated heat in the internal organs, particularly affecting the upper and middle jiao, manifesting as symptoms like vexation, thirst, oral ulcers, sore throat, constipation, and dark urine. It has been investigated in a clinical trial for intestinal dysfunctional intestinal dysfunction in sepsis.

Brand names: 绿叶凉膈散颗粒农本方浓缩中药配方颗粒凉膈散仙豐涼膈散濃縮細粒莊松榮涼膈散濃縮細粒
Other names: 凉膈散颗粒剂凉膈散Liang Ge San Granules

Beyond the preview

Go deeper on Cold Phrenic Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cold Phrenic Granules.

Explore the full profile